The Defense Health Agency’s new 2026 testosterone-deficiency screening policy is likely to generate questions in military households, particularly for male service members age 30 and older. The policy is real, but some headlines have made it sound as though every eligible service member will automatically receive a blood test or be encouraged to start testosterone therapy.
According to the Defense Health Agency, screening for men 30 and older is now part of periodic health assessments, entry examinations, or annual physicals. Men under 30 may be screened when they request it or when a clinician identifies a reason.
Screening starts with symptoms and risk factors
The initial process is described as a structured symptom and risk-factor assessment. When that screening suggests a possible deficiency, a clinician can decide whether laboratory testing or additional evaluation is appropriate.
That distinction can help families avoid unnecessary alarm. A screening result is not the same as a diagnosis, and a diagnosis is not an automatic prescription.
TRT can be an option, but it is not the only outcome
The DHA says testosterone replacement therapy or other hormone treatments may be discussed when a deficiency is identified. The treatment plan is supposed to be decided between the service member and military medical professionals and monitored over time.
Families researching the change can use this guide to military testosterone testing and TRT for a detailed explanation of the policy, active-duty referral issues, Guard and Reserve considerations, and fertility questions.
Fertility deserves attention
The Endocrine Society has publicly criticized broad population-level screening and raised concerns about fertility. Testosterone therapy can suppress sperm production, so service members who want children should make family-planning goals part of the conversation before beginning treatment.
Outside care can be complicated for active duty
TRICARE says active-duty members generally need referrals for care outside their assigned military hospital or clinic. A family considering private hormone care should therefore check military and TRICARE requirements before arranging treatment.
The most useful response to the new policy is not to assume that every low reading requires therapy. Ask what the screening found, what testing is needed, whether other conditions could explain symptoms, and what the military clinician recommends next.
